"Acetylglucosamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The N-acetyl derivative of glucosamine.
- 2 Acetamido 2 Deoxyglucose
- N Acetyl D Glucosamine
- 2 Acetamido 2 Deoxy D Glucose
Below are MeSH descriptors whose meaning is more general than "Acetylglucosamine".
Below are MeSH descriptors whose meaning is more specific than "Acetylglucosamine".
This graph shows the total number of publications written about "Acetylglucosamine" by people in this website by year, and whether "Acetylglucosamine" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Acetylglucosamine" by people in Profiles.
Synthetically glycosylated antigens induce antigen-specific tolerance and prevent the onset of diabetes. Nat Biomed Eng. 2019 10; 3(10):817-829.
Tuning carbohydrate density enhances protein binding and inhibition by glycosylated ?-sheet peptide nanofibers. Biomater Sci. 2018 Aug 21; 6(9):2327-2335.
Linking Cancer Metabolism to DNA Repair and Accelerated Senescence. Mol Cancer Res. 2016 Feb; 14(2):173-84.
N-acetylglucosaminylation of serine-aspartate repeat proteins promotes Staphylococcus aureus bloodstream infection. J Biol Chem. 2014 Feb 07; 289(6):3478-86.
A 4-deoxy analogue of N-acetyl-D-glucosamine inhibits heparan sulphate expression and growth factor binding in vitro. Exp Cell Res. 2010 Sep 10; 316(15):2504-12.
Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance. Nature. 2008 Feb 21; 451(7181):964-9.
Inhibition of amyloid A amyloidogenesis in vivo and in tissue culture by 4-deoxy analogues of peracetylated 2-acetamido-2-deoxy-alpha- and beta-d-glucose: implications for the treatment of various amyloidoses. Am J Pathol. 2004 Jun; 164(6):2127-37.
Novel glycosaminoglycan precursors as antiamyloid agents: Part IV. J Mol Neurosci. 2004; 24(1):167-72.
Oxazolidinone protection of N-acetylglucosamine confers high reactivity on the 4-hydroxy group in glycosylation. Org Lett. 2003 Apr 17; 5(8):1297-300.
Novel glycosaminoglycan precursors as anti-amyloid agents, part III. J Mol Neurosci. 2003; 20(3):291-7.